DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection

Blood

Volumn 95, Issue 3, 2000, Pages 1100-1105

  Vogt, M H J ^a   De Paus, R A ^a   Voogt, P J ^a   Willemze, R ^a   Falkenburg, J H F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; TRANSPLANTATION ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GRAFT REJECTION; HELA CELL; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE CLONE; PHENOTYPE; PRIORITY JOURNAL; Y CHROMOSOME;

EID: 0034141691     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.3.1100.003k42_1100_1105     Document Type: Article

References (30)

1. Voogt PJ, Fibbe WE, Marijt WA, et al. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet. 1990;35:131-134.
2. Bosserman LD, Murray C, Takvorian T, et al. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant. 1989;4:239-245.
3. Bunjes D, Heit W, Arnold R, et al. Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation. 1987;43: 501-505.
4. Marijt WA, Kernan NA, Diaz-Barrientos T, et al. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Bone Marrow Transplant. 1995;16:125-132.
5. Eichwald EJ, Silmser CR. Transplant Bull Skin. 1955;2:148-149.
6. Baily DW, Hoste J. A gene governing the female immune response to the male antigen in mice. Transplantation. 1971;11:404-407.
7. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Y-antigen killing by T cells of women is restricted by HLA. Nature. 1977;266:544-545.
8. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y [letter]. Lancet. 1976;2:1206-1206.
9. Bortin MM. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry. Transplant Proc. 1987;19:2655-2657.
10. Scott DM, Ehrmann IE, Ellis PS, et al. Identification of a mouse male-specific transplantation antigen, H-Y [see comments]. Nature. 1995;376:695-698.
11. Marijt WA, Veenhof WF, Goulmy E, Willemze R, van Rood JJ, Falkenburg JH. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. Blood. 1993;82:3778-3785.
12. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein [see comments]. Science. 1995;269:1588-1590.
13. Meadows L, Wang W, den Haan JM, et al. The HLA-A*0201 -restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity. 1997;6: 273-281.
14. King TR, Christianson GJ, Mitchell MJ, et al. Deletion mapping by immunoselection against the H-Y histocompatibility antigen further resolves the Sxra region of the mouse Y chromosome and reveals complexity of the Hya locus. Genomics. 1994;24:159-168.
15. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science. 1997;278:675-680.
16. Greenfield A, Scott D, Pennisi D, et al. An H-YDb epitope is encoded by a novel mouse Y chromosome gene. Nat Genet. 1996;14:474-478.
17. Millar AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 1993;217:581-599.
18. Kaashoek JG, Mout R, Falkenburg JH, Willemze R, Fibbe WE, Landegent JE. Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res. 1991;10:231-235.
19. Cluitmans FH, Esendam BH, Landegent JE, Willemze R, Falkenburg JH. Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes. Lymphokine Cytokine Res. 193;12: 457-464.
20. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]. J Exp Med. 1994;180:35-42.
21. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985;230:943-945.
22. de Bueger M, Bakker A, Goulmy E. Existence of mature human CD4+ T cells with genuine class I restriction. Eur J Immunol. 1992;22:875-878.
23. O'Reilly AJ, Affara NA, Simpson E, Chandler P, Goulmy E, Ferguson-Smith MA. A molecular deletion map of the Y chromosome long arm defining X and autosomal homologous regions and the localisation of the HYA locus Io the proximal region of the Yq euchromatin. Hum Mol Genet. 1992;1:379-385.
24. Cantrell MA, Began JS, Simpson E, et al. Deletion mapping of H-Y antigen to the long arm of the human Y chromosome. Genomics. 1992;13: 1255-1260.
25. Brown GM, Furlong RA, Sargent CA, et al. Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene. Hum Mol Genet. 1998;7:97-107.
26. Huang Y, Baker RT, Fischer-Vize JA. Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene. Science. 1995;270:1828-1831.
27. Kawauchi M, Gundry SR, de Begona JA, et al. Male donor into female recipient increases the risk of pediatric heart allograft rejection [see comments]. Ann Thorac Surg. 1993;55:716-718.
28. Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet. 1995;346:1117-1121.
29. Ogg GS, McMichael AJ. HLA-peptide tetrameric complexes. Curr Opin Immunol. 1998;10:393-396.
30. Tan LC, Gudgeon N, Annels NE, et al. Are-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol. 1999; 162:1827-1835.